A newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...

Shares in Sorrento Therapeutics rose 158% on Friday after it revealed plans to start human trials of an antibody therapy that achieved complete inhibition of the coronavirus in preclinical studies.

In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.

The COVAIL trial reveals that neutralizing antibody titers correlate with COVID-19 risk reduction after mRNA boosters. Learn how this impacts vaccine strategies against emerging variants.

By Dani Blum Dani Blum has reported on Covid since the spring of 2020 ... high-risk people before they get infected: a monoclonal antibody infusion called Pemgarda. And vaccines slash the risk ...

You're watching Coronavirus in Context. I'm Dr. John Whyte, chief medical officer at WebMD. What's the role of antibodies against coronavirus infection? It's one of the biggest questions that we ...

Further, the company estimates that every clinical variant reported in the CDC COVID Tracker since the Omicron BA.1 lineage has been susceptible to pemivibart, even if untested, due to the ...

Hopes that coronavirus antibody tests could help the UK end its lockdown have been dealt a blow - after the World Health Organization questioned whether they offer any guarantee of immunity.

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.